Gradient Pore Immunoisolation Membrane for Transplantation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing membranes for immunoisolation in transplantation are costly to manufacture and prone to deterioration in substance permeability due to protein adsorption, especially when they have small pore diameters, which can lead to immune rejection and reduced functionality over time.

Innovation Solution

A membrane with a porous structure that has a layered compact portion with a minimum pore diameter of 0.02 μm to 1.5 μm, where the pore diameter continuously increases from the compact portion towards the surface, made from polysulfone and polyvinylpyrrolidone, reducing protein adsorption and enhancing permeability while inhibiting immune cell infiltration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a porous membrane with small pore diameter is used for immunoisolation, then immune cell infiltration is inhibited, but substance permeability deteriorates due to protein adsorption

Engineering Contradiction:
Improveimmunoisolation effectivenessVSAvoidsubstance permeability
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The membrane structure transitions from uniform pores to a gradient structure where pore size varies by location. The compact portion has small pores (0.02-1.5 μm) for immunoisolation, while the spongy portion has larger pores for substance permeability. This local differentiation resolves the contradiction between blocking immune cells and allowing substance exchange.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention moves from considering only pore diameter (one dimension) to incorporating pore size gradient in the thickness direction (adding another dimension). The continuous increase in pore diameter from the compact portion toward the surface creates a three-dimensional pore size distribution that simultaneously achieves immunoisolation at the base and high permeability at the surface.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If a porous membrane with small pore diameter is used, then immune rejection is prevented, but manufacturing cost increases and substance permeability deteriorates

Engineering Contradiction:
Improveimmunoisolation effectivenessVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The invention changes the pore diameter parameter from a fixed small value to a gradient distribution ranging from 0.02-1.5 μm in the compact portion to larger values in the spongy portion. This parameter transformation allows the membrane to maintain immunoisolation effectiveness while improving substance permeability and reducing manufacturing complexity compared to ultrafine uniform pore membranes.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If pore diameter is small to prevent immune rejection, then immune cell infiltration is inhibited, but manufacturing precision requirements increase leading to defective products

Engineering Contradiction:
Improveimmunoisolation effectivenessVSAvoidpore diameter control
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The membrane is segmented into two functional portions: a compact portion with small pores for immunoisolation and a spongy portion with larger pores for permeability. This segmentation allows each portion to be optimized independently, with the compact portion providing the necessary immune barrier without requiring the entire membrane to have ultrafine uniform pores, thus reducing manufacturing precision requirements.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

By introducing the thickness direction as an additional dimension for pore size variation, the invention creates a pore size gradient that transitions from small pores at the base to larger pores toward the surface. This dimensional approach allows the membrane to achieve immunoisolation with smaller pores only where necessary while maintaining manufacturability.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The membrane is manufactured at lower costs, maintains substance permeability, and reduces immune rejection, allowing for long-term functionality by preventing immune cell infiltration and protein adsorption, thus ensuring effective nutrient and physiologically active substance exchange.

Implementation Method 1

A membrane for immunoisolation is a selectively permeable membrane which allows water, oxygen, glucose, or the like to permeate

Methodology Applied
Scientific EffectPermeation: Permeation

Implementation Method 2

a deterioration in substance permeability is likely to occur in general due to adsorption of proteins or the like

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS11051930B2Membrane for immunoisolation, chamber for transplantation, and device for transplantation
Publication Date: 2021.07.06 FUJIFILM CORP
  • US11051930B2 patent drawing
  • US11051930B2 patent drawing
  • US11051930B2 patent drawing

AI summary

According to the present invention, there are provided a membrane for immunoisolation, including: a porous membrane that contains a polymer, in which the porous membrane includes a layered compact portion where a pore diameter is the smallest within the membrane, and a pore diameter continuously increases in a thickness direction from the compact portion toward at least one surface of the porous membrane; a chamber for transplantation for enclosing a biological constituent therein, including the above-described membrane for immunoisolation on at least a part of a surface forming an inside and an outside of the chamber for transplantation; and a device for transplantation, including the above-described chamber for transplantation enclosing the biological constituent therein. In the membrane for immunoisolation of the present invention which can be manufactured at low costs, a deterioration in substance permeability is unlikely to occur.